Clinical Trial Update: Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update describes a study comparing clopidogrel-based antiplatelet therapy versus warfarin for secondary prevention in antiphospholip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome
• Stroke

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Warfarin (warfarin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Antiphospholipid Syndrome, Ischemic Stroke | Phase 4 | Status: RECRUITING